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ABSTRACT 
 
Spectral counting has become a widely used approach for comparing 
protein abundance in label-free shotgun proteomics. However, when 
analyzing complex samples, the ambiguity of matching between peptides 
and proteins greatly affects the assessment of peptide and protein 
differentiation. Meanwhile, the configuration of database searching 
algorithms that assign peptides to MS/MS spectra may produce different 
results. Here, I present three strategies to improve comparative proteomics 
through spectral counting.  I show that comparing spectral counts for 
peptide groups rather than for protein groups forestalls problems 
introduced by shared peptides. I present four models to combine four 
popular search engines that lead to significant gains in spectral counting 
differentiation. Among these models, I demonstrate a powerful vote 
counting model that scales well for multiple search engines. I also show 
that semi-tryptic searching outperforms tryptic searching for comparative 
proteomics. Overall, these techniques considerably improve protein 
differentiation on the basis of spectral count tables. 
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CHAPTER I 
 
 INTRODUCTION 
 
1.1 Overview 
Shotgun proteomics based on tandem mass spectrometry has become a widespread 
method for analyzing complex biological mixtures. It begins by digesting protein 
mixtures and separating the resulting peptides by liquid chromatography. After peptide 
MS/MS spectra are acquired, they are matched to database peptide sequences by 
search engines such as Sequest[1], Mascot[2], X!Tandem[3], and MyriMatch[4]. Proteins 
are assembled from these raw identifications by validation tools [5-9] that convert 
arbitrary search scores into statistical measures [10].  Proteins can then be filtered by 
customized criteria for further analysis. Because shotgun analyses can represent 
complex proteomes in considerable depth, a key question is how one can compare 
shotgun proteome inventories to reveal molecular characteristics of biologically distinct 
phenotypes to discover clinically important biomarkers. Improvement in protein 
differentiation broadly benefits the identification and validation of molecular markers 
that relate to various biological or medical outcomes, thus improving the current state 
of the art in biological research and clinical practice.  
In shotgun proteomics, the link between peptides and proteins is lost through the 
digestion of protein mixture. Determining which protein these shared peptides arose 
from is a challenge in comparative proteomics.  A particular peptide may correspond to 
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multiple potential protein sources. In systems where proteins of multiple species are 
present, such as xenograft models of cancer, shared peptides are very common, and so 
a difference in one protein may masquerade as a difference in a second protein that 
shares peptides with the first. 
Moreover, search results differ from one search engine to the next, depending on both 
the type of mass spectrometer used and the configuration of the search. In biological 
samples, often the most interesting proteins are lowest in abundance, and meaningful 
changes in protein abundance may be small in magnitude. Detecting these differences 
may be visible by one search engine but not another because of differences in match 
scoring. Even if the search engine is held constant, the way in which the tool is 
configured may significantly impact the set of identifications produced.  Deciding 
between a “fully tryptic” search and a “semi-tryptic” search would seem to primarily 
impact the amount of time required, but this decision has been shown to significantly 
alter the set of peptides identified from a mixture. 
Here, I characterize three strategies for improving comparative proteomics through 
spectral counting.  First, I will demonstrate that the problem of shared peptides can be 
resolved through comparison for peptide groups rather than proteins, giving examples 
of differences that would be confused by standard approaches.  Then, I will examine the 
gains achieved for spectral counting when collating search results from a set of four 
high-performance peptide identifiers.  I will also determine the impact of tryptic and 
semi-tryptic searching for spectral count tables to frame recommendations for best 
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practices.  Taken together, these techniques enable higher quality differentiation on the 
basis of spectral count tables. 
In this chapter, I will provide an introduction to shutgun proteomics, comparative 
shotgun proteomics, and the workflow of proteomics data analysis, including peptide 
identification, protein inference and protein assembly.  
 
1.2 Shotgun Proteomics 
Shotgun proteomics is currently the most commonly used approach for identification 
and quantification of large number of proteins. It has been proved to be successful in 
post-translational modification identification, protein quantification, and protein-
protein interaction[1]. The workflow of shotgun proteomics is illustrated in Figure 1. 
First, taking the sample of a mixture of proteins, reduce the complexity by SDS-PAGE or 
two-dimensional gel electrophoresis.  Then the proteins are digested into peptides by 
sequence-specific proteolysis. Trypsin is the most commonly used protease that cleaves 
peptide at the C-terminal side of arginine and lysine. The peptide mixtures are then 
separated by liquid chromatography and ionized in a mass spectrometry. Peptides are 
isolated in mass spectrometer and characterized by tandem mass spectrometry 
(MS/MS), which involves breaking the peptide into smaller fragments and measuring 
the mass spectrum of these fragments. During data analysis, the peptides are identified 
from the tandem mass spectra. Then proteins are assembled from the peptides. 
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Figure 1. The workflow of shotgun proteomics 
 
1.3 Comparative Shotgun Proteomics 
 An important goal in proteomics is to globally profile changes in protein abundances in 
biological systems, thus discovering protein expression state in response to biological 
perturbation, disease progression or drug treatment. In general, protein quantification 
by mass spectrometry is performed by stable isotope labeling or a label-free approach. 
A number of methods of stable isotope labeling of proteins or peptides, including 
Isotope-Code Affinity Tag (ICAT)[2], Stable Isotope Labeling by Amino Acids in Cell 
Culture (SILAC)[3], Isobaric Tags for Relative and Absolute Quantiﬁcation (iTRAQ)[4] are 
Peptide Mixture Liquid Chromatography Electrospray Ionization Mass Spectrometry
Isolate Ions of Peptide Collide Ions to Dissociate Collect Fragments in Tandem MS
Protein Mixture Protein DigestionBiological Sample Sample Fractionation
SDS-PAGE
2D-gel 
electrophoresis
Tandem Mass Spectra Peptide Identifications Confident Peptide List Assembled Protein List
5 
 
used. However, label based quantification methods have common limitations including 
requirements for higher amounts of biological samples, increased complexity in 
experiments, and high costs for the labeling reagents. Therefore, label-free shotgun 
proteomics have emerging and developed as an alternative for protein quantification 
and differentiation. Compared to label-based quantification, label-free quantification 
has the following advantages:  (a) There is no limit to the number of experiments to be 
compared while label-based approach, for example, SILAC is limited to 2-8 experiments 
that can be directly compared; (b) label-free methods provide higher dynamic range of 
quantification, thus will benefit analysis when large and global protein changes between 
experiments are observed[5]. Currently, two label-free quantification methods are used:  
(a) precursor intensity approach: measuring and comparing mass spectrometric signal 
intensity of peptide precursor ions of a given protein; (b) spectral counting approach:  
counting the number of MS/MS spectra matched to peptides of a given protein.  To use 
peptide precursor intensities, for every peptide, ion chromatograms are extracted from 
MS/MS run and their precursor MS peak areas or peak intensities are integrated over 
the chromatographic time or collected. The intensity for each peptide from one 
experiment can be compared to other experiments to yield relative quantitative 
information.   Prior work has demonstrated that a frequency-based analysis approach 
using the number of observed spectral counts for each protein provides a rough 
measure of protein levels in complex protein mixtures, especially for more abundant 
proteins[6-8]. Thus, relative abundance can be calculated by comparing the number of 
spectra between multiple experiments. 
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Comparing spectral counting and precursor intensity method, previous studies have 
shown that spectral counting can be as sensitive as ion peak intensities considering 
detection range, correlation and linearity. Spectral counting is more sensitive for 
detecting changes in protein abundance, whereas peak area provides more accurate 
estimates of protein ratios[9].  
Comparative proteomics spans two complementary goals.  First, researchers may seek 
to differentiate the proteomes of two sample cohorts, seeking the proteins that appear 
in one sample to a significantly greater degree than in another.  Second, researchers 
may seek to quantify the extent to which proteins change in magnitude between sample 
cohorts.  Here, I consider the first of these goals, leaving quantification as a topic for 
experimental methodologies better designed for this purpose, such as selected reaction 
monitoring[10] .  The evidence produced for a protein in “shotgun” experiments is the 
result of a high-throughput sampling process.  As a result, which spectra are captured 
from a particular protein digest will vary among experiments [11].  Spectral counts 
attributed to a particular protein group may vary due to random sampling or due to 
differences in protein quantity.  In general, one expects to collect both more spectra 
from individual peptides (potentially varying in charge state or modification state) as 
well as more peptides from a particular protein group as the concentration of that 
protein rises compared to the sample background.  As a result, finding significant 
differences requires the ability to compare variation in replicates to variation between 
cohorts. Here I focus on refining spectral counting method to achieve better protein 
differentiation.  
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1.4 Proteomic Data Analysis 
Usually, hundreds of thousands of tandem mass spectra are collected in a single 
shotgun proteomics experiment. Thus bioinformatics tools are required for proteomics 
data analysis.  
The typical proteomics data analysis workflow is shown in Figure 2. First, experimental 
spectra are interpreted as peptides with strategies discussed in next section. Next, 
peptide identifications are validated to estimate the false discovery rate of the 
confidence of the assignments. Peptides identified with high confidence are used to 
assemble proteins.  
 
Figure 2. Workflow of shotgun proteomics data analysis. 
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1.4.1 Peptide Identification 
Database search algorithms are essential to link tandem mass spectra (MS/MS) to 
peptide sequences from protein database. There are many search algorithms that are 
currently in use. Here I will introduce four major peptide identification approaches 
(Figure 3), with focus on four of the most popular search engines- Sequest[12], 
X!Tandem[13], MyriMatch[14] and TagRecon[15,16]. 
 
Sequence Database Search 
A general approach in Sequest, MyriMatch and X!Tandem are known as sequence 
database (DB) search. The overview of sequence database search is illustrated in Figure 
4. First, the experimental precursor ion mass of a peptide is compared with calculated 
peptide mass; database search tools perform an in-silico digestion of the protein 
database to enumerate all candidate peptide sequences that has the mass within the 
mass tolerance range. Then, tandem mass spectra are then matched to the fragment ion 
mass values. Corresponding mass values are counted or scored in a way that allows the 
identification of peptides best matches the data[17].  Database search tools then select 
the top ranked peptides of each spectrum for subsequent analysis. 
9 
 
 
Figure 3. Four peptide identification strategies  
Sequence DB search, spectral library search, sequence tag-assisted search and De novo 
sequencing search are used for peptide identification [18]. 
 
The scoring function is critical for measure the similarity between experimental and 
theoretical spectra. Scoring functions such as correlation fuctions (cross correlation in 
Sequest and dot product in X!Tandem) and probability-based function (ion score and 
identity score in Mascot and multivariate hypergeometric distribution score in 
MyriMatch) are used to evaluate the peptide-spectrum-matches (PSMs).   
Sequest uses a cross-correlation function to provide a measurement of similarity 
between mass-to-charge ratios for the fragment ions from the observed tandem mass 
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spectrum and the fragment ions predicted from amino acid sequences obtained from 
database. Difference between normalized cross-correaltion function of the first and 
second-ranked search results shows the confidence of match between sequence and 
spectrum.   
MyriMatch first stratifies peaks into multiple intensity classes, and then scores peptide 
matches based upon the multivariate hypergeometric (MVH) distribution on the basis of 
peak intensity. The scoring of peptides pays greater emphasis on matching intense 
peaks, which in result gains considerable discriminative power.   
X!Tandem generates theoretical spectra for the peptide sequences using knowledge of 
the intensity patterns associated with particular amino acid residues, and calculate an 
empirical E-value to access the significance of a peptide match. Peptide candidate score 
distributions are utilized for thresholding or E-value extrapolation. 
 
Figure 4. Overview of database search.  
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In these DB search tools, search parameters have great impact on search results.  First, 
precursor mass tolerance determines the peptide candidates to be compared to the 
experimental spectrum.  Mass tolerance window varies by instruments for collecting MS 
data, high mass accuracy instruments such as Orbitrap allow a very narrow mass 
window ~10ppm, while low mass accuracy instruments such as LTQ require a broader 
mass window  ~3 Da. Narrower mass window reduces search time and decreases 
number of false matches. Second, enzyme digestion specifications constraint also 
controls the number of candidate peptides to be analyzed. Tryptic search eliminates 
identification of peptides that undergo unexpected cleavages and spend less time than 
non-tryptic searches or semi-tryptic searches. I will discuss the difference further in the 
following sections. Other search parameters such as post-translational modifications 
and reference protein database can also affect search results.   
In spite of the wide spread usage of database search, database search tools rely heavily 
on protein databases, in which some of the genome sequences and annotation may not 
be accurate. Especially, mutations and modifications are often ignored by database 
search tools.  Moreover, database search is very time-consuming process for the large 
number of comparisons between observed spectra and theoretical spectra.  
 
Sequence tagging-based database search 
Sequence tagging-based database search first infers short peptide sequences (“tags”) 
from spectra.  The tags are then used to match candidate peptides via database search. 
Sequence tagging-based database search is particularly useful in the identification of 
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mutation and modifications. Tools such as InsPecT [19] and TagRecon[16] are examples 
of sequence tagging-based database search.   
TagRecon works with DirecTag as an integrated bioinformatics pipeline. DirecTag infers 
sequence tags from MS/MS spectra. TagRecon detects a sequence tag that matches a 
peptide sequence reconciling mass differences, and then compares the mass of flanking 
regions of both spectrum and peptide sequence to determine whether the masses 
matches is within a specified mass tolerance[16]. TagRecon uses two probabilistic 
subscores: an intensity-based probabilistic MVH score and a nonprobablistic fast cross-
correlation (XCorr) score to indicate the confidence of the PSMs.  
 
De novo sequencing search and spectral library search 
De novo sequencing infers peptide sequences directly from experimental spectra. The 
inferred peptides then mapped to proteins by downstream tools such as MS-BLAST[20]. 
This approach is especially useful when the organisms have unsequenced or partial 
sequenced genomes.  
Spectral library search matches MS/MS scans to a spectral library, a large collection of 
observed spectra that are confidently identified in previous experiments. It is a very 
efficient and accurate way for peptide identification. However, the assignment of 
peptides to observed spectra is largely affected by the completeness and accuracy of 
assembled spectral libraries.  
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Combining Search Engines 
The real proteomic samples are complex. Often the most interesting proteins are at low 
abundance and could not be discriminated due to the inference of other proteins and 
noises, especially when dealing with low quality spectra. Therefore, two search engines 
can provide very different results for the same sample [21]. 
Despite improvements in mass spectrometry instruments and peptide identification 
algorithms, a significant number of high quality MS/MS spectra left unassigned to 
peptide sequences or have scores below confidence thresholds[18]. This can be partially 
due to the deficiencies of scoring schemes implemented in the software to rank 
candidate peptides and select the best match for each experimental spectrum, resulting 
in loss of sensitivity in complex samples. A peptide may be identified by one search 
engine but blind to another due to their different scoring systems. Spectral counting 
depends upon identification, and yet little evaluation of its dependence on search 
engines has appeared in the peer-reviewed literature.  Integrating results from search 
algorithms is a promising strategy to improve peptide and protein identification 
confidence by reducing noise and utilizing complementary strengths.  Several 
approaches have been proposed for integrating search results. Alves et al. proposed 
combination of independent p-values from multiple search engines into a meta-analytic 
p-value for each peptide[22]. Searle et al. proposed a framework to combine the results 
of multiple search engines using Bayesian rules and the expectation maximization 
learning algorithm[23]. However, a peptide-centric model for combination of different 
search tools suffers from the difficulties from the lack of a common statistical standard. 
14 
 
Kwon et al. proposed a probabilistic approach by first converting raw search scores from 
search engines into a probability score for every possible PSM accounting for the 
correlation between scores, and control an unified false discovery rate for data 
integrated from different search engines[24]. Stepping beyond a single search scenario, 
researchers have demonstrated that collating results from multiple search engines 
improves sensitivity for inferring protein inventories [25,23,24], so long as false positives 
are kept under control.   It would seem that the improved coverage available through 
multiple search engines would be a boost for differentiation, as well.  How to leverage 
the increased information yield, however, has not yet been described.  
Here I will first compare the search results from different search engines on the same 
datasets in identifying differential proteins, then propose and compare four new 
approaches to combine search results at protein level, and examine the gains achieved 
for spectral counting when collating search results from a set of four high-performance 
peptide identifiers, thus providing new insights into integrating search tools to achieve 
better protein differentiation.  
 
1.4.2 Protein Inference 
Identification of peptides resulting from proteolytic digestion of proteins is only an 
intermediate step to identify and quantify proteins. The ultimate goal of a study is to 
identify and quantify proteins in the analyzed sample. One of the problems for protein 
differentiation arose from shared peptide in the task of assembling the sequences of 
identified peptides to infer protein content of the sample (Figure 5).  
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Figure 5. Protein inference in shotgun proteomics.  
 
 
 In this example, the sample contains two proteins, A and B, which share sequence homology. 
The three identified peptides, AEMK, GAGGLR, and HYFEDR are present in protein B, and 
GAGGLR, HYFEDR are present in protein A. in the shotgun approach, the connectivity between 
peptides and proteins are lost. No information on the number or properties of proteins in the 
samples is available. It is not possible to conclude the presence of A for B can account for all 
observed peptides[26].  
 For these peptides that are shared between two or more proteins, the abundance of 
the peptide is a combinational effect of multiple proteins, leading to ambiguities in 
protein differentiation by the redundancy. When using protein-based spectral count 
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differentiation, determining which protein these shared peptides arose from is a 
challenge to comparative proteomics.  After peptide validation, incorrect PSMs can still 
be accepted for protein inference.  A commonly used approach for protein inference 
and error estimation is to use a target-decoy strategy for database  search and apply 
various filters to control output proteins at a specific protein-level FDR. Protein filters 
including minimum number of distinct peptides to infer a protein, minimum number of 
spectra per protein and peptide FDR are usually used to remove incorrect proteins.   
Protein parsimony is widely accepted by proteomic community. The central idea is to 
present results of large scale shotgun experiments in terms of minimal lists of protein 
identifications.  Nesvizhskii et. al illustrated differentiation of proteins on the basis of 
identified peptides[26].  Zhang et. al  modeled peptide-protein relationships in a 
bipartite graph and identified protein clusters with shared peptides and to derive the 
minimal list of proteins[27]. The software- IDPicker, a protein assembly tool [28,27], 
organizes peptides into groups when they match identical sets of proteins, and it 
similarly organizes proteins into groups when they match identical sets of peptides 
(Figure 6). This structure enables the development of methods to differentiate 
proteomes in units of “peptide groups” that do not overlap with each other. This 
approach is based on the assumption that a high degree of similarity exists in the 
relative expression level of different proteins in the same protein group [29].  
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Figure 6. Protein assembly, protein groups and peptide groups in IDPicker 
In this diagram, three peptide groups are associated with two protein groups. IDPicker groups  
 
peptides, such as the two peptides in the orange box, to “peptide groups” when they match to 
exactly the same proteins- Histone-binding protein RBBP7 and RBBP4.   “Protein Groups” are 
sets of proteins such as RBBP4 and isoform 3 of RBBP4 that are indiscernible on the basis of the 
observed peptides.  Peptide groups that only associate with one protein group are called unique 
peptide groups (green box). Peptide groups that associate with more than one protein group are 
called shared peptide groups (orange box).Both the protein and peptide groups are shown in 
IDPicker reports.  
Several approaches have been proposed to improve the quantification and 
differentiation of proteins [30,27,29,31]. One approach is to discard shared peptides 
during protein quantification. However, previous studies have found that eliminating 
shared peptides from analysis eliminates protein inference but may significantly 
RBBP7 
RBBP4 
Isoform 3 of RBBP4 
EMFEDTVEER 
VHIPNDDAQFDASHCDSDK 
VINEEYK 
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18 
 
decrease the number of proteins for which relative abundance can be obtained[29]. 
Fermin et. al describes a method to adjust spectral counts to accurately account for 
peptides shared across multiple proteins by spectral counts of unique peptides. 
However, this approach has the risk of attempting to apportion large numbers of 
spectra on the basis of relatively small sets of differentiating spectra[30]. Here, I 
propose a new approach for protein differentiation based on peptide groups, which 
forestalls problems introduced by shared peptides.  
 
1.4.3 Tryptic Search vs. Semi-Tryptic Search 
In shotgun proteomics, proteins are usually digested by trypsin followed by liquid 
chromatography mass spectrometry. One of the problems is the low coverage of 
peptides when analyzing complex protein samples. It has been shown that only ~10-15% 
of all tryptic peptides from a given protein sample can be identified [32] by search 
engines.  Non-tryptic or semi-tryptic peptides are generated from the truncation of 
regular tryptic peptides before separation. In semi-tryptic search, one end, but not both 
of the peptide is allowed to diverge from the expected cleavage site. Peptide truncation 
can be caused by several factors such as in vivo biological mechanism or various 
chemical mechanisms during sample preparation, handling and storage. When searching 
peptide tandem mass spectra against sequence database, peptides identified are 
conformed to the search parameters-fully tryptic, semi-tryptic or non-tryptic, where a 
trade-off of false positives and false negatives will be yielded.  Deciding between a “fully 
tryptic” search and a “semi-tryptic” search would seem to primarily impact the amount 
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of time required, but this decision has been shown to significantly alter the set of 
peptides identified from a mixture [28].  Many research groups consider only peptides 
that under a rigorous “fully tryptic” cleavage rules for protein database search, whereas 
other groups allow “non-tryptic” or “semi-tryptic”peptides.  It has been shown that non-
tryptic peptide search overdoes the noice and specificity is impaired. Furthermore, it is 
much more complex to compute and requires a large and counter-productive increase 
in search time. Olsen et. al used the high mass accuracy of a linear ion-trap-FTICR mass 
spectrometer to exclude precursor ions with less than 1 p.p.m mass accuracy and found 
that trypsin cleaves solely C-terminal to arginine and lysine[33]. This work provided 
evidence to support fully tryptic search.  However, the rigorous mass filter excluded the 
non-tryptic peptides, which composed a large portion of the overall experimental 
peptides. Moreover, this result is not applicable to lower sensitivity and mass accuracy 
experiments. It is found that although for a given protein, semi-tryptic peitdes might be 
generated at lower probability than the tryptic peptides, a high concentration protein 
often contribute large numbers of semi-tryptic peptides comparative to tryptic peptides 
of low concentration proteins in being selected for fragmentation[28]. However, the 
impact of trypsin specificity configurations on protein differentiation has not been 
considered in depth.  Deciding between a “fully tryptic” search and a “semi-tryptic” 
search has been shown to significantly alter the set of peptides identified from a mixture 
[28,34].  Here, I compare the fully tryptic and semi-tryptic search in protein 
differentiation, and generalize the conclusion in two datasets with different sensitivity 
and mass accuracy. 
20 
 
CHAPTER 2 
 
 MATERIALS AND METHODS 
 
2.1 Data Sources 
 
2.1.1 ABRF Data 
I used a dataset from the Association of Biomolecular Research Facilities (ABRF) iPRG 
2009 study. In that study, two samples of E.coli lysates (labeled “red” and “yellow”) 
were digested with trypsin then analyzed with LC-MS/MS on an LTQ-Orbitrap with five 
technical replicates for each sample. The Red and Yellow replicates were derived from 
the same E. coli lysate sample running on two halves of one gel with a single region 
excised from each half  (The “Green” and “Blue” proteomic data sets) . Proteins in the 
changing region of red and yellow cohorts were enriched in Blue and Green cohorts 
respectively (for more information see Figure S1 in Supplementary Information).  A 
differential protein key list was built by comparing the differentially expressed proteins 
between the less complex Blue and Green cohorts with significance level 0.05. 85% of 
the proteins in the key list corresponded with the mass regions excised from the gel. 
The proteins significantly expressed in the Blue cohort that were also significantly 
expressed in the Red cohort were considered as true positives. Similarly, the proteins 
significantly expressed in the Green cohort that were also significantly expressed in the 
Yellow cohort were considered as true positives.  
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2.1.2 CPTAC Data 
 I used a dataset created by the Clinical Proteomic Technology Assessment for Cancer 
(CPTAC) program [11]. In the study, a yeast lysate was spiked with a mixture of 48 
human proteins (Sigma-Aldrich UPS1) at several levels of concentrations. Each sample 
was analyzed with triplicates on seven independent instruments of four models 
(Thermo Fisher LTQ, LTQ-XL, LTQ-XL-Orbitrap, and LTQ-Orbitrap). Groups A, B, C, D, E 
were yeast spiked with UPS-1 at 0.25, 0.74, 2.2, 6.7, and 20 fmol/ul respectively. Data 
were processed using a FASTA database combining the yeast and human proteomes. 
Search parameters are provided in Supplemental File1.   
 
2.1.3 HNSCC Data 
The Head and Neck Tissue Repository [35] collected 20 head and neck squamous cell 
carcinomas (HNSCC) from all patients undergoing surgery in head and neck area at 
Vanderbilt University.  These cancerous samples can be compared to 20 normal 
tonsillectomy tissues which were collected from pediatric tonsillectomies performed at 
Vanderbilt Children’s Hospital. Tissues were snap-frozen in liquid nitrogen and kept at -
80  °C until processing. Tumor samples were macrodissected to achieve a minimum of 
70% tumor cells in the specimen to be analyzed. Epithelial cells were dissected away 
from lymphoid cells in normal specimen. The tissues were embedded in polyvinyl 
alcohol, which was then removed with wash with deionized water.  Peptides were 
separated by isoelectric focusing and cut into 20 fractions. Each of these fractions was 
analyzed by liquid chromatography, followed by MS/MS analysis on a LTQ-Orbitrap. 
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2.1.4 ASW480 Data 
 Adenomatous polyposis coli (APC) is a negative regulator of Wnt signaling. Mutation of 
APC occurs in up to 60% of colorectal cancer (CRC) tumors. Halvey et. al in Vanderbilt 
University has examined the proteomics of two colon tumor cell lines- SW480APC (APC 
restored), SW480Null (mutant APC). Cells were grown in RPMI 1640 medium, 
supplemented with 10% fetal bovine serum, 1% penicillin/streptomycin and genetecin 
(1.5 mg/ml), then lysed at ambient temperature. Proteins were reduced and alkylated 
with 40 mM tris(2-carboxyethyl)phosphine (TCEP)/100 mM dithiothreitol (DTT) and 50 
mM iodoacetamide (IAM), respectively.  Samples were diluted in 50 mM AmBic, pH 8.0 
and tyrpsinized overnight at 37 °C (1:50, w:w).  Subsequently, peptides were lyophilized 
overnight.  Peptides were desalted as described [36], and separated by isoelectric 
focusing (IEF) using immobiline IPG strips (24 cm, pH 3.5-4.5) (GE Healthcare) as 
described.[36,37]  . LC-MS-MS shotgun proteomic analyses were performed on LTQ XL 
mass spectrometer (Thermo Fisher Scientific) equipped with an Eksigent NanoLC AS1 
autosampler and Eksigent NanoLC 1D Plus pump, Nanospray source, and Xcalibur 2.0 
SR2 instrument control. Peptides were separated on a packed capillary tip (Polymicro 
Technologies, 100 mm × 11 cm) with Jupiter C18 resin (5 mm, 300 Å, Phenomenex) 
using an in-line solid-phase extraction column (100 mm × 6 cm) packed with the same 
C18 resin using a frit generated with liquid silicate Kasil 1. Mobile phase A consisted of 
0.1% formic acid and mobile phase B consisted of 0.1% formic acid in 90% acetonitrile. A 
90-min gradient was carried out with a 30-min washing period (100% A) to allow for 
solid-phase extraction and removal of any residual salts. Following the washing period, 
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the gradient was increased to 25% B by 35 min, followed by an increase to 90% B by 50 
min and held for 9 min before returning 95% A. MS-MS spectra of the peptides are 
acquired using data-dependent scanning in which one full MS spectrum (mass range 
400-2000 m/z) is followed by five MS-MS spectra.  MS-MS spectra are recorded using 
dynamic exclusion of previously analyzed precursors for 60 s with a repeat of 1 and a 
repeat duration of 1. MS/MS spectra were generated by collision-induced dissociation 
of the peptide ions at normalized collision energy of 35% to generate a series of b- and 
y-ions as major fragments. Biological samples from 3 independent cell cultures were 
injected in duplicate for a total of 6 replicate measurements for the SW480null and 
SW480APC cell lines. A subset of proteins found to be differentially expressed by LC-
MS/MS were validated by targeted proteomics (LC-MRM-MS).  For all 22 proteins that 
were validated by targeted proteomics, label free shotgun proteomics data and LC-MRM 
data were broadly concordant, and identical trends in protein expression were observed 
between the two platforms[38].  
 
2.2 Database Search Pipeline 
MS/MS scans were converted to mzML file format by the msConvert tool in the 
ProteoWizard[39] library to provide input files for TagRecon (TR)[16], MyriMatch (MM) 
and X!Tandem (XT) search. These files were then converted to DTA format by 
ScanSifter[40,16] to enable Sequest (SQ) search.  All protein databases contained 
sequences in both forward and reverse orientations for estimation of protein and 
peptide identiﬁcation error rates .For LTQ data, MM, TR, and XT applied a precursor 
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tolerance of 1.25 m/z, while SQ applied a 2.5 Da mass tolerance. For Orbitrap data, MM 
and XT applied a precursor tolerance of 10 or 40 ppm, while TR applied 0.01 m/z 
tolerance and SQ applied a 0.1 Da mass tolerance.  The search results were processed by 
IDPicker to yield a 5% or 2% False Discovery Rate (FDR). Peptides passing these 
thresholds were considered as legitimate identiﬁcations. IDPicker assembled protein 
identiﬁcations from peptides using parsimony rules [27,28]. 
Statistically significant differences in protein spectral counts between different groups 
were calculated using quasi-likelihood Generalized Linear Modeling (GLM) by 
QuasiTel[35]. Proteins with p-values less than 0.05 were considered as differential 
proteins.  Differentially expressed proteins were mapped to genes and compared for 
enrichment of defined classes against a reference set of all identified proteins. Search 
configurations, dataset information, and identified peptides are shown in Table S1, S4 
and Supplementary material 2. 
 
2.3 Model for Peptide Group-Based Spectral Count Differentiation 
IDPicker generates tables reporting the number of spectral counts for each peptide 
group (Figure 6). I used Fisher’s Exact Test instead of GLM to compute a p-value for each 
peptide group because the GLM includes additional covariates in the comparisons which 
may diminish accuracy for peptide groups with low spectral counts. I also used Fisher’s 
Exact Test to compute a p-value for each protein group as a comparison method.  I 
employed the Benjamini-Hochberg FDR method to correct p-values for multiple 
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hypothesis testing [41].   Statistical techniques for the peptide group-based analysis 
differed from those employed in the search algorithm combination and semi-tryptic 
evaluations.  These latter examinations employed the standard QuasiTel GLM for 
differentiation. 
Common data analysis practices in comparative proteomics reflect the belief that FDR 
(multiple hypothesis testing corrected p-value) is good both as a qualitative and a 
quantitative indicator of the overall significance of the results. The use of FDR based 
meta-analysis was previously demonstrated in ChIP-chip meta-analysis [42]. The 
corrected p-values of peptide groups corresponding to the same protein group were 
combined using Stouffer’s z-reverse normal transform method [43] to estimate the 
significance level of changes at the protein group level.   
The weighted Stouffer’s inverse normal transform method I built, described in equation 
(1) and (2), took peptide p-value, sample size and effect direction (4) into consideration 
to compute a protein p-value. Optimal weights for the weighted Z method were given 
by the square root of the spectral counts of peptide groups divided by their occurrence 
in protein groups (3). By this strategy, unique peptide groups are assigned higher 
weights than the shared peptides. 
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(4) 
*   and    denote the standard normal cumulative distribution function and 
its inverse.  
 
2.4 Models for Combining Search Engines 
I present statistical models to combine search results from four search engines. 
Heterogeneity among search engines results from factors including spectral pre-
processing, theoretical spectrum prediction, and match scoring algorithms.  As a result, 
FDR-based meta-analysis was necessary to summarize results. In the first model, 
spectral counts from each search engine were added together prior to differentiation. 
The combined spectral counts were analyzed by QuasiTel and corrected by the FDR 
method to compute p-values. In the second model, I computed FDR corrected p-values 
of protein spectral counts separately by search engine. These p-values were then 
combined for each protein using Stouffer’s Z-transform probability test [44].  In the third 
model, I ranked the proteins by FDR corrected p-values from individual search engines 
(from smallest to largest). The ranks were then added together to compute a super rank 
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for each protein. In the “Stouffer p-combo Model” and “p-Rank Sum Model,” proteins 
that were not identified by any included search engine were excluded in the comparison.  
Vote counting is well described for use in microarrays and peptide identifications [45,46]. 
Rhodes et al used a comparative meta-profiling which assesses the overlap of gene 
expression differentiation from a diverse collection of microarray datasets. Several 
modifications enable its use for protein spectral count differentiation. Briefly, the 
spectral count data were analyzed by QuasiTel, and p-values from individual search 
engines were FDR corrected. I then defined a significance threshold –α (αDEFAULT=0.05) 
and the number of top proteins I wanted to select –NSELECT For these thresholds, I then 
ranked proteins by the number of search engines that find each significant; this 
positions each search engine as a “voter.” Within each class of proteins with the same 
vote-counts, I then ranked proteins by the minimum of their p-value from the combining 
search engines (minimum p-value, increasing).This process ranked potential protein 
differences, with the most substantial changes at the top. 
Assessing FDR for vote counts and best p-values followed a permutation strategy.  First, 
I counted the proteins for each possible number of vote counts (N1, N2…NS).  Permuting 
the p-values per search engine among proteins generated a set of randomly produced 
differences.  I counted these differences for each possible number of vote counts (E1, 
E2…ES). The minimum meta-false discovery rate (mFDRmin) can then be calculated by: 
                
[    ]
[  ]
)              
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Then I assess the validity of α with the following criteria: If mFDRmin<α, these proteins 
were found to be differentially expressed at the threshold α. If not, I repeated the 
enumeration of votes with the value of α lowered by 20% at each iteration until either a 
valid α is defined or the number of differential proteins detected in two or more search 
engines reaches 0. A valid α should not fall so far that the number of proteins with at 
least one vote was less than NSELECT. Furthermore, to be strict in the significant level of 
the threshold, I should find the smallest (most significant), valid α setting by lowering α 
by 20% and repeat the previous validity testings iteratively. The algorithm was 
implemented in R (Supplementary Material 3).  This model is tuned for the best 
performance when voter turnout is large, i.e. more search engines are deployed for 
each data set. 
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CHAPTER 3 
 
 RESULTS AND DISCUSSION 
 
3.1 Peptide Group-Based Spectral Count Differentiation Improves 
Protein Differentiation 
Peptide group-based spectral count differentiation better evaluates the impact of 
unique and shared peptide groups on protein differentiation, thus effectively reducing 
false positives. This method is most effective in reducing false positives when working 
with proteomic samples of higher organisms where a lot of shared peptide groups exist.  
Therefore, I tested the technique in ASW480 and HNSCC human proteomic datasets. In 
the ASW480 dataset, 6042 peptide groups were identified, mapping to 7325 proteins in 
5215 protein groups. I compared the cell line with and without the APC vector with 
protein group-based and peptide group-based techniques after MyriMatch search and 
IDPicker filtering. Of the differentiating proteins discovered by peptide group analysis, 
95% were also discovered through protein group analysis.  Correspondingly, 81% of the 
differential proteins from protein-based differentiation were also identified by peptide 
group-based differentiation (Figure S2, S4). At first, this would seem to imply higher 
sensitivity to differences in protein group analysis, perhaps due to more aggressive p-
value correction in the more numerous peptide group comparisons.  Only 5 proteins 
were identified exclusively by peptide group-based differentiation, while 21 proteins 
were differentiated by protein-based but not peptide-based techniques. I examined 
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these 21 proteins with a critical eye.  In the example of protein groups for Desmin and 
Vimentin, four peptide groups were shared between Desmin and Vimentin and six other 
protein groups (Table S2). The p-values of Desmin and Vimentin from protein-based 
spectral count differentiation were 0.0230 and <0.0001 respectively, signifying that 
these two proteins were both differentially expressed. However, I found that the 
spectral count of the unique peptide group of Desmin had not significantly changed (p-
value>0.05). Desmin and Vimentin share four peptide groups that were also shared by 
2-4 other protein groups, causing cross-talk between these proteins and others that 
were legitimately changing. The spectral count of these peptide groups greatly impacted 
the total spectral count of Desmin.  These data demonstrate that shared peptides can 
cause unchanging proteins to become false positive differences. 
The p-value for Desmin was 0.1551 when differentiation was performed at the level of 
peptide groups with combination via Stouffer’s inverse normal method[43].  Separating 
peptides by protein association revealed that the expression level of Desmin had not 
significantly changed.  On the other hand, the change of Vimentin level remained 
significant (p-value <0.0001). In fact, the lack of change for Desmin was reinforced by 
microarray (p-value of 0.9875) [38]. On the other hand, the enrichment analysis of 
proteomic data revealed that targets of transcription repressor ZEB1 were measured at 
lower levels in the SW480 Null cell line, implying elevated ZEB1 activity in this cell line. 
Others have shown that disruption of the ZEB1/SMARCA4 binding causes an increase in 
CDH1 expression and a decrease in Vimentin [47]. I also compared the two methods 
between replicates of APC or control group which I knew should not show any 
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differential proteins. Peptide-group based differentiation reduced the false positive 
differentiation by 20-41% (Figure S3).  These facts have shown that peptide group-based 
differentiation is robust against false positives induced by shared peptides.   
Peptide group based-spectral count differentiation is also more sensitive to changes in 
unique peptide groups. In the HNSCC dataset, 4011 proteins were assembled to 2569 
protein groups, with 2941 peptide groups mapping to them.  100 differential proteins 
were identified by peptide group-based differentiation (Figure S2). As a test, I evaluated 
the biomarker set resulting from a comparison using only the peptide groups that 
mapped to a single protein group; limiting the information to this set of peptides, 
however, reduced detection of differentiating proteins by 22% (Figure S2). Of the 
proteins found to be differences from the peptide group-based technique employing all 
peptides, 94% were also found through the protein-based technique.  Of the protein-
based difference set, 82% were also observed through peptide-group differentiation.  A 
majority of protein changes found by peptide group-based differentiation shared 
peptides with other protein groups. Myosin 14 was among the differences found by 
peptide group-based but not protein group-based techniques.  This non-muscle myosin, 
which appears to play a role in cytokinesis and cell shape, was matched to five peptide 
groups (Table S3). Protein-based spectral count differentiation could not provide 
enough evidence (p-value =0.2580>0.05) to show that myosin14 was differentially 
expressed in cancer group versus control group. However, when I look closely into each 
peptide group, I find that the peptide group that contains sequences specific to this 
form of myosin changes significantly in spectral counts, increasing from 39 to 110 (2.82 
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fold, p-value=0.0004<0.05). By peptide group based spectral count differentiation, the 
difference is significant (p-value=0.0016<0.05). Previous studies have shown that 
overexpression of myosin14 inhibits cell growth [48], which coincides with the 
heightened expression in normal samples.  Without peptide group-based comparison, 
this difference would be masked by other myosin forms.  
Generally, protein and peptide group-based differentiation are highly concordant with 
each other (Figure S4). The correlation coefficient for the p-values of ASW480 proteins 
was 0.9470, while the HNSCC set yielded a 0.9420 correlation.  After finding the 
differential proteins by p-values, the fold change of a protein can be estimated by 
averaging the fold change of its peptides. Because there are more peptide groups than 
protein groups for an assembly, multiple testing adjustment reduces the count of 
significant differences more strongly for peptide groups than for protein groups. For 
example, of the 20 proteins that were disagreements between the two differentiation 
techniques in the ASW480 dataset, three proteins (CD2 antigen cytoplasmic tail-binding 
protein 2, Envoplakin, Heat shock protein beta-1) are proteins with only one peptide 
group. As a result, the set of spectral counts compared in protein group and peptide 
group techniques are the same.  Once multiple testing correction has been applied, 
though, Envoplakin shifts to a 0.0446 p-value from protein group evaluation or to an 
insignificant 0.0581 p-value from peptide group evaluation. Whether this constitutes the 
removal of a false positive difference or losing sensitivity for real differences cannot be 
resolved from the data on hand. 
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3.2 Combining Multiple Search Engines Improves Protein 
Differentiation 
 
Protein differentiation is considerably affected by search algorithms. In the ABRF iPRG E. 
coli dataset, 1275 proteins in total were identified by the four search engines, while only 
662 proteins were shared between all four search engines.  The ability to identify truly 
differentiated proteins also varied among different search engines. MM, TR, XT, and SQ 
each identified 228, 225, 226, 207 truly differentiated proteins, respectively (Figure S5). 
Most truly differential proteins (derived from identifications in the “blue” and “green” 
samples) reach agreement between two or more search engines with consistent fold 
change directions. These results highlighted the necessity of combining search engines 
to detect more correct differences and reduce false discoveries. I applied four distinct 
models (see Methods) to combine different search engines. These models have shown 
their unique advantages to achieve better protein differentiation. I ranked the proteins 
by p-values from the “Count Sum Model” and “Stouffer p-combo Model” and by super 
rank of “p-Rank Sum Model” from smallest to largest, or by vote-counts from the “Vote 
Counting Model” from largest to smallest and chose the top 250 proteins 
(approximately the length of the key list) for true positive and false positive analyses. As 
shown in Figure 7, generally, combinations of search engines outperform individual 
search engines. For the pairing of SQ and TR, the “Stouffer p-combo Model” increased 
AUC by 12.7%, from 79.6% to 89.7%, and identified 18 more true positive proteins than 
TR by itself. Combining all four search engines by the “p-Rank Sum Model” identified 
3%-13% more true positive proteins than for any individual search engine; this 
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combination revealed that adding all possible search engines is not guaranteed to 
outperform a well-selected set of search engines, since the MM+TR+SQ combination 
was more effective.  Of the search engine pairs, XT and SQ appeared least effective at 
complementing each other. 
 
 
Figure 7. Number of true positive proteins out of the Top 250 of proteins of corresponding 
combination of search engines in ABRF E.coli dataset. 
 
 
  In “Count Sum Model”, results from different search engines are combined by adding 
spectral counts together, in “Stouffer p-combo Model”, p-values form different search 
engines are combined by Stouffer’s method. In “p-Rank Sum Model”, proteins were 
ranked by p-value from individual search engine (from smallest to largest). The ranks are 
added together to compute a super rank for each protein. In the “Vote Counting Model”, 
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proteins were ranked by the number of search engines deeming them significant 
along with the best individual search engine p-value. 
Combining all the four search engines with the “Vote Counting Model” produced the 
best true positive ratio and lowest false positive ratio, with 177 true positives out of top 
250 differences, while the best number of true positives of other models is only 167. 
The “Vote Counting Model” identified 20.5%, 22.1% 22.1% and 22.9% more true positive 
proteins than searching by MM, TR, XT or SQ individually. Combining three search 
engines such as MM+TR+SQ is also effective.  
 
Figure 8. Number of true positive proteins in top 50 differentiated proteins using different 
combination of search engines in CPTAC Study6 dataset.  
 
Combinations of search engines by these models were also evaluated in the context of 
the CPTAC LTQ dataset. I used data from C and E cohorts (a 9 fold difference of UPS-1 
spike concentration). In total, 45 out of 48 UPS-1 proteins were identified by the four 
search engines. MM, TR, XT, SQ identified 42,42,41,40 UPS-1 proteins respectively 
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(Figure S6). I ranked the proteins by p-values, super rank or vote-counts and analyzed 
the top 50 proteins with the four models. Numbers of true positives among the top 50 
proteins were compared in Figure 8. Again, combinations of search engines 
outperformed individual search engines for revealing protein differences.  Combining TR 
and SQ with the “Stouffer p-combo Model” generated 32% more true positives than SQ 
individually. Combining all four search engines by the “Count Sum Model” identified 
17.9%-50.0% more true positive proteins than individual search engines. 
Again, combining all the four search engines with the “Vote Counting Model” produced 
one of the best true positive ratio and lowest false positive ratio, with 33 true positives 
out of top 50 differences. The “Vote Counting Model” identified 17.9%, 43.5% 22.2% 
and 50.0% more true positive proteins than searching by MM, TR, XT or SQ individually. 
The advantage is not distinctive here because of the small number of proteins in the 
“answer key.” Combining only two search engines was helpful for one data set but not 
the other; the voting model benefits from a larger pool of votes (Figure 7, 8). For 
example, MM+XT, TR+XT, MM+TR only identified around 150 true positive proteins.  In 
the ABRF data set, only the combinations that included Sequest gave the highest 
performance, though this algorithm working alone had yielded the lowest number of 
true differences. 
The four models for combining search engines have different strengths and weaknesses. 
In simply adding spectral counts for a protein identified by multiple search engines, a 
single spectrum might be counted multiple times. Although the multiple counting 
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increases the confidence of identification and spectral count differentiation, it will get 
extreme p-values because of the correlation between search results. In the “Stouffer p-
combo Model”, combining p-values among algorithms increases the sensitivity of the 
collective analysis, but has risks of bias towards idiosyncratically significant p-values of 
one search engine. In the “p-Rank Sum Model”, the super rank comprises a non-
parametric assessment of the results from individual engines. Drawing conclusions 
about which of these techniques is best would over-generalize from the two sample sets 
evaluated in this study, though combination is clearly beneficial. The “Vote Counting 
Model” was most powerful when combining more search engines. Overall, combining 
search engines improves protein differentiation by not only increasing the protein 
inventories, but also increasing the pool of information available to differentiate each 
protein. Each combination of search engines allows for better discrimination than any 
individual search engine. 
 
3.3 Semi-Tryptic Search Outperforms Tryptic Search in Protein 
Differentiation 
A given search engine may yield different performance depending on its configuration.  
Bioinformaticists have argued for years that semi-tryptic searching, which allows the 
identification of peptides that differ from canonical trypsin specificity on one terminus, 
improves the inventories possible from proteomics[49]. I tested this parameter for its 
impact on comparative proteomics.  Table S4 reports the number of identified peptides 
by fully-tryptic and semi-tryptic searches. 
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I first compared Red/Yellow cohorts in the iPRG E.coli dataset. All the other 
configurations and analysis were identical. Figure 9 shows the ROC curve of 
differentiated protein expression with semi-tryptic or fully tryptic searches.  Semi-tryptic 
search achieved better sensitivity and specificity than fully tryptic search, with AUC 
increased by 6% (from 83.77% to 88.56%). Similarly, when comparing true positive and 
false positive proteins at the cut point of p-value 0.05, semi-tryptic search greatly 
increases true positive proteins by 7.07% for the same number of false positives. The 
improvement reveals that semi-tryptic search achieves better sensitivity and specificity 
than fully tryptic search for a sample in which many proteins offer stark differences 
between cohorts.
 
Figure 9.  Comparison of fully tryptic and semi-tryptic searching in ABRF dataset.  
 
{A} ROC curve of differentiated proteins expression using semi-tryptic and fully tryptic search in 
the iPRG dataset. {B} True positives and false positives at p-value of 0.05 discovered through 
semi-tryptic and fully tryptic search.   
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I next analyzed the CPTAC dataset (where the spiked proteins differed by a factor of 
three between each pair of five levels) with fully tryptic and semi tryptic search. I 
compared the spectral counts of proteins in these cohorts in pairs (Table 1). I chose a 
sampling of the possible fold changes, preferring samples where spike concentrations 
were greater.  Semi- tryptic search generally outperformed fully tryptic search in AUC.  
Especially in D and E cohorts, where UPS1 proteins were most dominant, semi-tryptic 
search increased AUC by 5.5% (from 86.76% to 91.50%).  
 
Table 1. Fully tryptic versus semi tryptic search in Yeast Sample with Spiked Human 
Proteins  
 
 Fully tryptic  Semi tryptic 
 True 
positive/false 
positive 
Average 
Spectral 
Count 
Ratio 
Area 
Under 
Curve 
True 
positive/false 
positive 
Average 
Spectral 
Count 
Ratio 
Area 
Under 
Curve 
 27-fold difference 
B versus E 30/20 10.74 0.9786 32/18      12.36 0.9827 
A versus D 25/25 9.67 0.9939 27/23 12.62 0.9944 
 9-fold difference 
C versus E 29/21 4.84 0.9777 31/19 4.33 0.9779 
B versus D 22/28 2.45 0.9799 25/25 6.76 0.9765 
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 3-fold difference 
D versus E 21/29 1.95 0.8676 24/26 2.12 0.9150 
C versus D 21/29 2.53 0.8290 24/26 2.48 0.8841 
B versus C 9/41 3.25 0.8859 14/36 3.21 0.8942 
 
*The amount of UPS-1 (Sigma-Aldrich) proteins that spiked in A, B, C, D, E are 0.24, 0.67, 2.7, 6.7, 
20 (fmol/µg yeast) respectively. 
*Geometric average is calculated by geometric mean of the ratio : 
                            )                             )⁄   , group 1 and group 2 indicates 
the comparison pairs. For spike in protein that is not found in the search results, their spectral 
counts are set as zero. 
The top 50 (approximately the number of proteins in the gold standard) most 
differentiated proteins for each pairwise comparison were evaluated against the list of 
proteins known to change, and the numbers of true positives and false positives were 
computed (TP/FP).  At different spike levels, semi-tryptic search detects more true 
positive proteins along with fewer or unchanged false positive proteins.  Especially in B 
vs C, which contained only small amounts of spiked proteins with a three-fold 
concentration difference, semi tryptic search identified 55% more true positives than 
fully tryptic search.  Generally, semi tryptic search provides better sensitivity and 
specificity than fully tryptic search, especially when comparing groups with small spike-
in protein concentration changes (D vs E, C vs D).  
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Why would adding semi-tryptic peptide improve protein differentiation? When an 
algorithm fails to identify a spectrum, a semi-tryptic search will typically assign a semi-
tryptic peptide to the spectrum (because random semi-tryptic peptides outnumber 
fully-tryptic peptides by more than an order of magnitude).  Software that separates 
correctly identified spectra from incorrectly identified ones exploits this information to 
identify a larger set of peptides, even if no semi-tryptic peptides are present.  The most 
abundant proteins in a mixture are, in turn, more likely to produce semi-tryptic peptides 
in addition to fully-tryptic peptides. As the concentration of UPS-1 proteins increases 
from group A to group E, the percentage of semi-tryptic peptides from these UPS-1 
proteins was 0% in group A and group B. The percentage increased to 6.9% -7.0% in 
group C and group D, and reached the highest-10.6% in group E.   The increased 
identification of semi-tryptics from dominant proteins increases the power of semi-
tryptic search in protein differentiation and expands the dynamic range of 
differentiation. 
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CHAPTER 4 
 
 CONCLUSIONS 
 
Spectral count differentiation benefits from a peptide group-based evaluation strategy, 
new models for combining database search engines, and care in search configuration.  
Peptide group-based spectral count differentiation helps to resolve the protein 
inference problem, giving particular power when untangling complex protein-peptide 
clusters. It can be used as an alternative or complementary differentiation method 
when working with complex comparative proteomic samples where a lot of shared 
peptide groups exist. In systems where proteins of multiple species are present, such as 
xenograft models of cancer or other samples that contain proteins from multiple 
eukaryotes, the method has great potential in improving protein differentiation. Due to 
the influence of multiple testing adjustment, this method may lose power for proteins 
near the p-value threshold. 
Three of the four tested models for combining search engines for differentiation proved 
to be effective.  The “Count Sum Model” can be easily implemented for almost any 
workflow and delivers solid performance, though false positives may prove problematic.  
The “p-Rank Sum Model” may be more robust against idiosyncratic performance for 
individual search engines. These two models can be used when combining two or three 
search engines; in this examination, MM+TR+SQ yielded the best performance. With the 
increased ability of incorporating three or more search engines, the “Vote Counting 
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Model” is very robust against idiosyncratic results for individual search engines.  Its 
steady, high performance in these datasets suggested great potential for fielding many 
search engines at once. 
These models may be most useful in biomarker discovery, where some proteins of 
interest are at low abundance.  The use of multiple engines can broaden the pool of 
information available to differentiate proteins present at small quantities. These models 
can also apply to samples with large genomes when low-resolution mass analyzers have 
measured precursor masses; these searches compare very large numbers of candidate 
sequences to every spectrum, thus losing discrimination. In the future, these models 
may be developed by recognizing the unique contribution of each search engine. The 
search engines that provide more confident IDs with better sensitivity and specificity, 
such as MM in the two datasets above, should be afforded more importance. In the 
“Count Sum Model,” excluding the overlapping peptide spectrum matching by different 
search engines can also be used to reduce the type I error.  
In both datasets, semi-tryptic peptide search outperforms fully tryptic peptide search in 
protein differentiation studies in multiple aspects including higher discovery rate, better 
specificity, and better sensitivity. Semi-tryptic search is more sensitive to small protein 
concentration changes. Ignoring the contributions of semi-tryptic peptides would 
sacrifice discrimination for levels of abundant proteins. If endogenous proteases are 
present in a sample, semi-tryptic search is obviously the choice for better protein 
differentiation, but the improved inventories are feasible through this option even in 
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samples dominated by fully-tryptic peptides. In the future, more general conclusions can 
be drawn by in-depth analysis of trypsin specificity configurations by search engines 
other than MM.  
In conclusion, these three strategies yield higher quality differentiation based on 
spectral counting.  These strategies are each generic enough to enable their 
incorporation in many bioinformatics pipelines.  Since the spectral counting strategy 
was introduced in 2004, it has become a standby for many laboratories.  These advances 
will enable its application to samples where proteins share peptides in complex 
relationships, discrimination of correct peptides requires multiple pipelines, and a wide 
dynamic range of proteins is interrogated. 
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APPENDIX A 
 
Supplementary Materials 1 
 
Table S1.    Data sets, Search Engines, Protein Sequence Databases used in this study. 
 
Dataset replicate
s 
Instrumen
t  
average 
No. of 
MS2 
scans 
Sequence 
databases 
MyriMatc
h 
Tagrecon X!Tandem Sequest 
Precursor 
mz 
tolerance/
fragment 
mz 
tolerance 
Precursor 
mz 
tolerance/fr
agment mz 
tolerance 
Parent 
monoisoto
pic mass 
error 
/fragment 
monoisoto
pic mass 
error 
Peptide 
mass 
tolerance/fr
agment ion 
tolerance 
ASW480  6 LTQ 12124 Uniprot-
Human-
20110701 
1.25/0.5 \ \ \ 
HNSCC 1 Orbitrap 28230 Uniprot-
Human-
20110701 
0.1/0.5 \ 
 
\ \ 
ABRF- 
Ecoli 
5 Orbitrap 17496 UniProt-
ECOLI-
20110208 
10ppm 
/0.5 
0.01/0.5 40 ppm/0.5 
daltons 
0.1/0.0 
CPTAC-
Yeast 
3 LTQ 261485 Uniprot-
Yeast and 
Human 
1.25/0.5 1.25/0.5 +3.0 -0.5 
daltons/0.5 
Daltons 
2.5/0.0 
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Table S2.  Peptide-to-protein Table of Desmin and Vimentin in ASW480 Dataset 
 
Peptide Group 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
Total 
Spectral 
Count of  
Proteins 
 
p-value 
Protein 
group 
based  
p-value 
Peptide 
group 
based  
p-value 
Occurence 
Only 
in 
Desm 
Shared 
by 
DESM, 
VIM 
and 2 
other  
protein 
groups 
Shared 
by 
DESM, 
VIM and  
2 other 
protein 
groups 
Shared 
by 
DESM, 
VIM and 
4 other 
protein 
groups 
Shared 
by 
DESM, 
VIM 
Only in 
VIM 
   
Spectra Count 
 APC/Null 
7/8 14/19 10/7 23/40 19/42 338/613    
P-value of 
individual 
peptide group 
1 1 1 0.4699 0.0879 4.30E-21    
Desmin(DESM) X X X X X  73/116  0.0232 0.1551 
Vimentin(VIM)  X X X X X 404/721 <0.0001 <0.0001 
 
Peptides corresponding to each peptide group are shown in Supplemental Material 4. 
 
Table S3. Peptide-to-protein Table of Myosin 14 in HNSCC Dataset 
 
Peptide 
Group 
1 
 
2 
 
3 
 
4 
 
5 
 
Total Spectral 
Count of  
Protein 
 
p-value 
Protein 
group 
based  p-
value 
Peptide 
group 
based  p-
value 
53 
 
Occurence 
Unique 
peptide 
group of 
myosin 
14 
Shared 
by 
myosin 
14, and 
3 other 
protein 
groups 
Shared 
by 
myosin 
14, and 
2 other 
protein 
groups 
Shared 
by 
myosin 
14 and 
2 other  
protein 
groups  
Shared 
by 
myosin 
14 and 
myosin 
9 
   
Spectra 
Count 
(Cancer/Ctrl) 
39/110 23/19 14/9 4/3 4/4 84/145   
P-value of 
individual 
peptide 
group 
0.0004 0.8260 0.7185 1 1    
Myosin 14 X X X X X  0.2584 0.0016 
 
Peptides corresponding to each peptide group are shown in Supplemental Material 4.  
 
Table S4. Average number of fully and semi-tryptic peptides confidently identified (rank1) 
by both searches  
 
 
  
 ABRF Dataset CPTAC Dataset 
Fully-
tryptic 
search 
Semi-tryptic 
search 
Fully-tryptic 
search 
Semi-tryptic 
search 
Number of Peptides 16581 16988 41209 49199 
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Figure S1.  The “Red/Yellow” iPRG 2009 LC-MS/MS data set with “Blue/Green” LC-MS/MS 
answer keys. 
 
 
source:  
http://www.abrf.org/ResearchGroups/ProteomicsInformaticsResearchGroup/Studies/iP
RG2009_presentation.pdf  
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Figure S2. Venn diagram of differentially expressed proteins at protein level and peptide 
group level in two datasets 
 
A     B       
 
Figure S2 Venn diagram of differentially expressed proteins at protein level, peptide 
group level and with only unique peptides in {A} ASW480, {B} HNSCC dataset.  With our 
method of protein differentiation at peptide group level, I identified 96 differential 
proteins in ASW480 dataset and 100 proteins in HNSCC dataset with 94-95% 
overlapping with protein based differentiation. When using peptide-based 
differentiation with only unique peptides, I will lose 7-22% differential proteins with few 
gains.  
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 Figure S3. Venn diagram of differentially expressed protein at protein and peptide group 
level in ASW480 replicates of the same groups 
 
A      B 
  
Figure S3 Venn diagram of differentially expressed protein at protein and peptide group 
level in ASW480 dataset comparing replicates of {A} control groups (Ctrl-Pro, Ctrl-Pep) 
or {B} APC groups (APC-Pro, APC-Pep) respectively. There should not be differential 
proteins between replicates of either control or APC group, thus these identified 
proteins are false discoveries. I can see that peptide group based differentiation 
effectively reduces false positives.  
 
Figure S4. Correlation coefficient between protein and peptide group-based p-values 
 
A. ASW480                    B.   HNSCC   
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Figure S4. The Correlation coefficient between protein and peptide group-based p-
values are {A} 0.9472 (ASW480  Dataset) and   {B}  0.9422 (HNSCC Dataset); 
Figure S5.  Venn diagram comparing the differential proteins identified by different search 
engines in ABRF dataset 
 
A                                                                                                  B 
  
Figure S5: Venn diagram comparing the differential proteins identified by different 
search engines –Myrimatch (MM), X!tandem(XT) Tagrecon (TR) and Sequest (SQ) in 
ABRF dataset. {A}Venn diagram of proteins that identified by four different search 
engines.  The number of proteins identified by MM, TR, XT, SQ are 934, 891, 863, 772 
respectively.   {B} Venn diagram of truly differential proteins identified by four different 
search engines.  Of the 193 truly differential proteins identified by all four search 
engines, only 3 proteins showed inconsistent fold change directions among search 
engines.  Average pairwise correlation of fold changes between search engines is 0.9109.  
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Figure S6.   Venn diagram comparing the differential proteins identified by different search 
engines in CPTAC dataset 
 
  
Figure S6: Venn diagram comparing the differential proteins identified by different 
search engines –Myrimatch (MM), X!tandem(XT) Tagrecon (TR) and Sequest (SQ) in 
CPTAC study 6 dataset. {A} Venn diagram of proteins that identified by four different 
search engines.  The number of proteins identified by MM, TR, XT, SQ are 744, 701, 651, 
672 respectively.   {B} Venn diagram of UPS-1proteins identified by four different search 
engines. MM, TR,XT,SQ have identified 42,42,41,40 UPS-1 proteins respectively. All the 
33 truly differential proteins identified by all four search engines showed consistent fold 
change directions among search engines.   
  
A        B 
59 
 
 
APPENDIX B 
 
Supplementary Materials 2 
 
MyriMatch Configurations 
 
ABRF and HNSCC Dataset Configurations 
 
PrecursorMzTolerance= 10 ppm    
FragmentMzTolerance = 0.5 
FragmentMzToleranceUnits = daltons 
 
AdjustPrecursorMass    = true  
MinPrecursorAdjustment = -1.008665  
MaxPrecursorAdjustment = 1.008665  
PrecursorAdjustmentStep = 1.008665  
NumSearchBestAdjustments = 3 
 
DuplicateSpectra = true 
UseChargeStateFromMS = true 
NumChargeStates = 4 
UseSmartPlusThreeModel = true 
TicCutoffPercentage    = 0.95 
 
CleavageRules =  "trypsin" 
NumMaxMissedCleavages =  2 
NumMinTerminiCleavages =  1 (for semi tryptic search  or 2 for fully tryptic search) 
UseAvgMassOfSequences = false 
MinCandidateLength =  5 
 
DynamicMods = "M ^ 15.9949 (Q * -17.026" 
MaxDynamicMods = 2 
StaticMods = "C 57.0215" 
60 
 
 
ComputeXCorr = true 
 
CPTAC Dataset Configuration 
PrecursorMzTolerance= 1.25 
PrecursorMzToleranceUnits = daltons 
FragmentMzTolerance = 0.5 
FragmentMzToleranceUnits = daltons 
 
AdjustPrecursorMass = false 
MinPrecursorAdjustment = -1.008665 
MaxPrecursorAdjustment = 1.008665 
PrecursorAdjustmentStep = 1.008665 
NumSearchBestAdjustments = 3 
 
DuplicateSpectra = true 
UseChargeStateFromMS = false 
NumChargeStates = 3 
UseSmartPlusThreeModel = true 
 
CleavageRules =  "trypsin" 
NumMaxMissedCleavages =  2 
NumMinTerminiCleavages =  1 
UseAvgMassOfSequences = true 
MinCandidateLength =  5 
 
DynamicMods = "M ^ 15.9949 (Q * -17.026 C @ 57.021" 
MaxDynamicMods = 3 
StaticMods = "" 
 
ComputeXCorr = true 
 
DecoyPrefix = "rev_" 
 
MaxResults = 5 
 
ASW480 Dataset Configuration 
PrecursorMzTolerance= 1.25 
FragmentMzTolerance = 0.5 
 
DuplicateSpectra = true 
UseChargeStateFromMS = false  
NumChargeStates = 3 
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UseSmartPlusThreeModel = true 
TicCutoffPercentage = 0.98 
 
CleavageRules =  "trypsin" 
NumMaxMissedCleavages =  2 
NumMinTerminiCleavages =  2 
UseAvgMassOfSequences = true 
MinCandidateLength =  5 
 
DynamicMods = "M ^ 15.9949 (Q @ -17.026 ( $ 42.015" 
MaxDynamicMods = 3 
StaticMods = "C 57.0215" 
 
MaxResults = 5 
ComputeXCorr = true 
 
 
 
Sequest Configurations 
 
ABRF Dataset Configuration 
database_name =/hactar/home/yaoyi/fasta/20110208-UniProt-ECOLI-Cntms-
reverse.fasta 
first_database_name =/hactar/home/yaoyi/fasta/20110208-UniProt-ECOLI-Cntms-
reverse.fasta 
second_database_name =  
peptide_mass_tolerance = 0.1 
create_output_files = 1                ; 0=no, 1=yes 
ion_series = 0 1 1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 
fragment_ion_tolerance = 0.0           ; leave at 0.0 unless you have real poor data 
num_output_lines = 5                   ; # peptide results to show 
num_description_lines = 5              ; # full protein descriptions to show for top N peptides 
num_results = 500   ; # of results to process 
show_fragment_ions = 0                 ; 0=no, 1=yes 
print_duplicate_references = 1         ; 0=no, 1=yes 
enzyme_number = 0        # 0.  No_Enzyme        1.  Trypsin_Strict   KR            2.  Trypsin   
KRLNH 
diff_search_options = 15.994915 M 57.021464 C 
term_diff_search_options = 0.000 0.000; c term, n term diff mods 
max_num_differential_AA_per_mod = 3    ; max # of modified AA per diff. mod in a 
peptide 
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nucleotide_reading_frame = 0           ; 0=proteinDB, 1-6, 7=forward three, 8=reverse 
three, 9=all six 
mass_type_parent = 1                   ; 0=average masses, 1=monoisotopic masses 
mass_type_fragment = 1                 ; 0=average masses, 1=monoisotopic masses 
remove_precursor_peak = 0              ; 0=no, 1=yes 
ion_cutoff_percentage = 0.0            ; prelim. score cutoff % as a decimal number i.e. 0.30 
for 30% 
protein_mass_filter = 0 0              ; enter protein mass min & max value ( 0 for both = 
unused) 
max_num_internal_cleavage_sites = 2   ; maximum value is 5; for enzyme search 
match_peak_count = 0                   ; number of auto-detected peaks to try matching (max 
5) 
match_peak_allowed_error = 1           ; number of allowed errors in matching auto-
detected peaks 
match_peak_tolerance = 1.0             ; mass tolerance for matching auto-detected peaks 
partial_sequence =    
 
CPTAC Dataset Configuration 
database_name =/hactar/fasta/20080131-SGD-BSA-Cntm-Human-reverse.fasta 
first_database_name =/hactar/fasta/20080131-SGD-BSA-Cntm-Human-reverse.fasta 
second_database_name =  
peptide_mass_tolerance = 2.5 
create_output_files = 1                ; 0=no, 1=yes 
ion_series = 0 1 1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 
fragment_ion_tolerance = 0.0           ; leave at 0.0 unless you have real poor data 
num_output_lines = 5                   ; # peptide results to show 
num_description_lines = 5              ; # full protein descriptions to show for top N peptides 
num_results = 500   ; # of results to process 
show_fragment_ions = 0                 ; 0=no, 1=yes 
print_duplicate_references = 1         ; 0=no, 1=yes 
enzyme_number = 1                           ; # 0.  No_Enzyme        1.  Trypsin_Strict   KR            2.  
Trypsin   KRLNH 
diff_search_options = 15.9949 M 
term_diff_search_options = 0.000 0.000; c term, n term diff mods 
max_num_differential_AA_per_mod = 3    ; max # of modified AA per diff. mod in a 
peptide 
nucleotide_reading_frame = 0           ; 0=proteinDB, 1-6, 7=forward three, 8=reverse 
three, 9=all six 
mass_type_parent = 0                   ; 0=average masses, 1=monoisotopic masses 
mass_type_fragment = 1                 ; 0=average masses, 1=monoisotopic masses 
remove_precursor_peak = 0              ; 0=no, 1=yes 
ion_cutoff_percentage = 0.0            ; prelim. score cutoff % as a decimal number i.e. 0.30 
for 30% 
63 
 
protein_mass_filter = 0 0              ; enter protein mass min & max value ( 0 for both = 
unused) 
max_num_internal_cleavage_sites = 2   ; maximum value is 5; for enzyme search 
match_peak_count = 0                   ; number of auto-detected peaks to try matching (max 
5) 
match_peak_allowed_error = 1           ; number of allowed errors in matching auto-
detected peaks 
match_peak_tolerance = 1.0             ; mass tolerance for matching auto-detected peaks 
partial_sequence =    
sequence_header_filter =  
 
 
add_C_Cysteine = 57.0215               ; added to C - avg. 103.1388, mono. 103.00919 
 
 
 
 
TagRecon Configurations 
 
ABRF Dataset Configuration 
PrecursorMzTolerance= 0.01 
FragmentMzTolerance = 0.5 
NTerminusMzTolerance =  0.5 
CTerminusMzTolerance =  0.5 
 
AdjustPrecursorMass =  false 
 
DuplicateSpectra = true 
UseChargeStateFromMS = true 
NumChargeStates = 4 
UseSmartPlusThreeModel = true 
TicCutoffPercentage = 0.98 
 
CleavageRules =  "trypsin" 
NumMaxMissedCleavages = 2  
NumMinTerminiCleavages =  1 
UseAvgMassOfSequences = false 
 
DynamicMods = "M ^ 15.9949 C @ 57.021" 
MaxDynamicMods = 3 
StaticMods = "" 
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ExplainUnknownMassShiftsAs = "preferredptms" 
PreferredDeltaMasses = "( 42.015 (Q -17.026 N -17.023 [DES] 21.981 [WYF] 15.996 W 
3.994 W 31.989  K 92.105 R 185.628 C 88.62 C 47.73 (C 39.902" 
MaxNumPreferredDeltaMasses = 2 
 
Blosum = “blosum62.fas" 
UnimodXML = "unimod.xml" 
BlosumThreshold = -4 
 
ComputeXCorr = true 
MinCandidateLength =  5 
 
MaxResults = 5 
 
CPTAC Dataset Configuration 
PrecursorMzTolerance= 1.25 
FragmentMzTolerance = 0.5 
NTerminusMzTolerance =  1.5 
CTerminusMzTolerance =  1.25 
 
DuplicateSpectra = true 
UseChargeStateFromMS = false 
NumChargeStates = 3 
UseSmartPlusThreeModel = true 
TicCutoffPercentage = 0.98f 
 
CleavageRules =  "trypsin" 
NumMaxMissedCleavages = 2  
NumMinTerminiCleavages =  1 
UseAvgMassOfSequences = true 
MinCandidateLength =  5 
 
DynamicMods = "M ^ 15.9949 (Q * -17.026 C @ 57.021" 
MaxDynamicMods = 3 
StaticMods = "" 
# Path to the unimod.xml and blosum.fas files. These files are packaged with the 
installation. 
UnimodXML = /hactar/home/dasaris/bumbershoot/src/tagrecon/unimod.xml 
Blosum = /hactar/home/dasaris/bumbershoot/src/tagrecon/blosum62.fas 
 
ComputeXCorr = true 
 
MaxResults = 5 
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X!Tandem Configurations 
 
ABRF Dataset Configuration 
         <enzymatic_search_constraint enzyme="trypsin" 
max_num_internal_cleavages="1" min_number_termini="1" /> 
         <aminoacid_modification aminoacid="C" massdiff="57.0215" mass="160.0307" 
variable="N" /> 
         <aminoacid_modification aminoacid="C" massdiff="-17.0265" mass="143.0042" 
variable="Y" symbol="^" /><!--X! Tandem n-terminal AA variable modification--> 
         <aminoacid_modification aminoacid="E" massdiff="-18.0106" mass="111.0320" 
variable="Y" symbol="^" /><!--X! Tandem n-terminal AA variable modification--> 
         <aminoacid_modification aminoacid="M" massdiff="15.9949" mass="147.0354" 
variable="Y" /> 
         <aminoacid_modification aminoacid="Q" massdiff="-17.0265" mass="111.0321" 
variable="Y" symbol="^" /><!--X! Tandem n-terminal AA variable modification--> 
          
         <!-- Input parameters --> 
         <parameter name="output, histogram column width" value="30"/> 
         <parameter name="output, histograms" value="no"/> 
         <parameter name="output, maximum valid expectation value" value="1"/> 
         <parameter name="output, parameters" value="yes"/> 
         <parameter name="output, path" value="C:\chen\ABRF-iPRG-
2009\xmls\sh_072808p_E_coli_ABRF_red.xml"/> 
         <parameter name="output, path hashing" value="no"/> 
         <parameter name="output, performance" value="yes"/> 
         <parameter name="output, proteins" value="yes"/> 
         <parameter name="output, results" value="all"/> 
         <parameter name="output, sequences" value="yes"/> 
         <parameter name="output, sort results by" value="protein"/> 
         <parameter name="output, spectra" value="yes"/> 
         <parameter name="output, title" value="Orbi X!Tandem"/> 
         <parameter name="protein, C-terminal residue modification mass" value="0.0"/> 
         <parameter name="protein, N-terminal residue modification mass" value="0.0"/> 
         <parameter name="protein, cleavage semi" value="yes"/> 
         <parameter name="protein, cleavage site" value="[RK]|[7]"/> 
         <parameter name="protein, taxon" value="UniprotHuman"/> 
         <parameter name="refine" value="no"/> 
         <parameter name="refine, maximum valid expectation value" value="0.1"/> 
         <parameter name="refine, spectrum synthesis" value="yes"/> 
         <parameter name="residue, modification mass" value="57.0215@C"/> 
         <parameter name="residue, potential modification mass" value="15.9949@M"/> 
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         <parameter name="scoring, maximum missed cleavage sites" value="1"/> 
         <parameter name="scoring, minimum ion count" value="4"/> 
         <parameter name="spectrum, dynamic range" value="100.0"/> 
         <parameter name="spectrum, fragment monoisotopic mass error" value="0.5"/> 
         <parameter name="spectrum, fragment monoisotopic mass error units" 
value="Daltons"/> 
         <parameter name="spectrum, maximum parent charge" value="4"/> 
         <parameter name="spectrum, minimum fragment mz" value="150.0"/> 
         <parameter name="spectrum, minimum parent m+h" value="500.0"/> 
         <parameter name="spectrum, minimum peaks" value="15"/> 
         <parameter name="spectrum, parent monoisotopic mass error minus" 
value="10"/> 
         <parameter name="spectrum, parent monoisotopic mass error plus" value="10"/> 
         <parameter name="spectrum, parent monoisotopic mass error units" 
value="ppm"/> 
         <parameter name="spectrum, parent monoisotopic mass isotope error" 
value="yes"/> 
         <parameter name="spectrum, path type" value="mzxml"/> 
         <parameter name="spectrum, threads" value="1"/> 
         <parameter name="spectrum, total peaks" value="50"/> 
         <parameter name="spectrum, use contrast angle" value="no"/> 
         <parameter name="spectrum, use noise suppression" value="no"/> 
 
CPTAC Dataset Configuration 
     <enzymatic_search_constraint enzyme="trypsin" max_num_internal_cleavages="1" 
min_number_termini="1" /> 
         <aminoacid_modification aminoacid="C" massdiff="57.0215" mass="160.0307" 
variable="N" /> 
         <aminoacid_modification aminoacid="C" massdiff="-17.0265" mass="143.0042" 
variable="Y" symbol="^" /><!--X! Tandem n-terminal AA variable modification--> 
         <aminoacid_modification aminoacid="E" massdiff="-18.0106" mass="111.0320" 
variable="Y" symbol="^" /><!--X! Tandem n-terminal AA variable modification--> 
         <aminoacid_modification aminoacid="M" massdiff="15.9949" mass="147.0354" 
variable="Y" /> 
         <aminoacid_modification aminoacid="Q" massdiff="-17.0265" mass="111.0321" 
variable="Y" symbol="^" /><!--X! Tandem n-terminal AA variable modification--> 
          
         <!-- Input parameters --> 
         <parameter name="protein, C-terminal residue modification mass" value="0.0"/> 
         <parameter name="protein, N-terminal residue modification mass" value="0.0"/> 
         <parameter name="protein, cleavage semi" value="yes"/> 
         <parameter name="protein, cleavage site" value="[RK]|[7]"/> 
         <parameter name="protein, taxon" value="20110726-Yeast-Human"/> 
         <parameter name="refine" value="no"/> 
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         <parameter name="refine, maximum valid expectation value" value="0.1"/> 
         <parameter name="refine, spectrum synthesis" value="yes"/> 
         <parameter name="residue, modification mass" value="57.0215@C"/> 
         <parameter name="residue, potential modification mass" value="15.9949@M"/> 
         <parameter name="scoring, maximum missed cleavage sites" value="1"/> 
         <parameter name="scoring, minimum ion count" value="4"/> 
         <parameter name="spectrum, dynamic range" value="100.0"/> 
         <parameter name="spectrum, fragment monoisotopic mass error" value="0.4"/> 
         <parameter name="spectrum, fragment monoisotopic mass error units" 
value="Daltons"/> 
         <parameter name="spectrum, maximum parent charge" value="4"/> 
         <parameter name="spectrum, minimum fragment mz" value="150.0"/> 
         <parameter name="spectrum, minimum parent m+h" value="500.0"/> 
         <parameter name="spectrum, minimum peaks" value="15"/> 
         <parameter name="spectrum, parent monoisotopic mass error minus" 
value="0.5"/> 
         <parameter name="spectrum, parent monoisotopic mass error plus" value="3.0"/> 
         <parameter name="spectrum, parent monoisotopic mass error units" 
value="Daltons"/> 
         <parameter name="spectrum, parent monoisotopic mass isotope error" 
value="no"/> 
         <parameter name="spectrum, path type" value="mzxml"/> 
         <parameter name="spectrum, threads" value="2"/> 
         <parameter name="spectrum, total peaks" value="50"/> 
         <parameter name="spectrum, use contrast angle" value="no"/> 
         <parameter name="spectrum, use noise suppression" value="no"/> 
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APPENDIX C 
 
Supplementary Materials 3 
 
R Code Implementation for Vote Counting Model 
data<-read.table("input path",sep="\t", header=T) 
 
##The input file should be with the columns: label Protein [MM TR XT SQ 
(whatever search engines to combine)] 
protcount <- length(data[,1]) 
summary(data) 
 
 
 
votesum_TP<-function(alpha,no.proteins,searchEngines){ 
#this function takes a p-value threshold, number of top proteins you want to choose, 
#and for this trained dataset, it also calculate number of true positives in the top 
proteins  
##The input is like: 
##votesum_TP(0.05,250,cbind(data$MM,data$XT,data$TR,data$SQ)) 
##The output is  like: 
##votesum==0  votesum==1  votesum==2  votesum==3   votesum==4   True positives in 
top N proteins' 
 
 
no_engines=length(searchEngines[1,]) 
searchEng_p=matrix(rep(NA,protcount*no_engines),nrow=protcount,ncol=no_engines) 
vot_sum=rep(NA,protcount) 
 
min_searchEngine=rep(NA,protcount) 
 
for (i in 1:protcount){ 
 for(j in 1:no_engines){ 
 if(!is.na(searchEngines[i,j])&&searchEngines[i,j]<=alpha) 
  searchEng_p[i,j]=1 
 else 
  searchEng_p[i,j]=0 
} 
vot_sum[i]=sum(searchEng_p[i,]) 
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if(sum(is.na(searchEngines[i,]))<no_engines){ 
min_searchEngine[i]=min(searchEngines[i,],na.rm=TRUE)} 
} 
list=data.frame(data,vot_sum) 
sort.vot <- list[order(vot_sum,-min_searchEngine,decreasing = TRUE) , ] 
TP_Top=sum(sort.vot$label[1:no.proteins]) 
 
vot_result=rep(NA,no_engines+1) 
for (i in 0:no_engines){ 
vot_result[i+1]=length(subset(vot_sum,vot_sum==(i)))} 
 
return (c(vot_result,TP_Top)) 
} 
 
Calc_FDRmin=function(alpha,no.proteins,searchEngines){ 
##this function simulates permutations of p-values of each search engine among 
proteins, and calculates a minimum FDR   
 
no_engines=length(searchEngines[1,]) 
 
N_sum=votesum_TP(alpha,no.proteins,searchEngines) 
 
sim=cbind(data$label,data$Protein) 
for (i in 1:no_engines){ 
sim=cbind(sim,sample(searchEngines[,i]))} 
 
E_sim_sum=votesum_TP(alpha,no.proteins,sim[,3:(3+no_engines-1)]) 
ratio=(E_sim_sum+1)[1:(no_engines+1)]/N_sum[1:(no_engines+1)] 
mFDRmin=min(ratio) 
num_threshold_engines=which(ratio==mFDRmin)-1 
return(c(mFDRmin,num_threshold_engines)) 
} 
 
 
 
eval_alpha=function(alpha,no.proteins,searchEngines){ 
##This function evaluates the validity of threshold with three criteria 
##(1) If mFDRmin<a, these proteins were found to be differentially expressed at the 
threshold a.  
##(2) If not, I repeated the enumeration of votes with the value of a lowered by 20% at 
each iteration until either a valid a is defined or the number of differential proteins 
detected in two or more search engines reaches 0.  
##(3) A valid a should not fall so far that the number of proteins with at least one vote 
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was less than N SELECT. 
 
 
no_engines=length(searchEngines[1,]) 
if(sum(votesum_TP(alpha,no.proteins,searchEngines)[3:(3+no_engines-2)])==0){ 
##two or more signatures reached 0 
 return(0) 
} 
actual_alpha=Calc_FDRmin(alpha,no.proteins,searchEngines) 
if(actual_alpha[1]<alpha){ 
      ## if none of these proteins are at this threshold can yield no. of proteins  
   ##This criteria is to avoid too small alpha 
  if(sum(votesum_TP(alpha,no.proteins,searchEngines)[2:(2+no_engines-
1)])<no.proteins){ 
  #not enough proteins have significant p-values at this threshold, please 
increase alpha' 
  return(0)  } 
  else{  
  #SUCCESS 
  return(alpha)  }} 
 
##this is to avoid too big alpha 
else{ 
  eval_alpha(alpha*.8,no.proteins,searchEngines) 
  } 
} 
 
find_alpha=function(alpha,no.proteins,searchEngines){ 
##this function finds the smallest (most strict) p-value threshold that is valid through 
eval_alpha validity test  
while(eval_alpha(alpha*0.8,no.proteins,searchEngines)!=0){ 
alpha=alpha*0.8} 
return(alpha) 
} 
 
###################################################### 
##User input area 
 
 
no.proteins=50 
start_alpha=0.1 
 
 searchEngines=cbind(data$MM,data$XT,data$SQ,data$TR) 
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# searchEngines=cbind(data$MM,data$XT,data$TR) 
# searchEngines=cbind(data$MM,data$XT,data$SQ) 
# searchEngines=cbind(data$MM,data$TR,data$SQ) 
# searchEngines=cbind(data$XT,data$TR,data$SQ) 
 
# searchEngines=cbind(data$XT,data$TR) 
# searchEngines=cbind(data$MM,data$TR) 
# searchEngines=cbind(data$MM,data$XT) 
# searchEngines=cbind(data$MM,data$SQ) 
# searchEngines=cbind(data$XT,data$SQ) 
# searchEngines=cbind(data$TR,data$SQ) 
 
 
###THE OUTPUT 
PART************************************************************ 
no_engines=length(searchEngines[1,]) 
#must specify the number of protein list that you want from the begining 
 
result_alpha=find_alpha(start_alpha,no.proteins,searchEngines) 
print(paste('The best p-value threshold for highest sensitivity and specificity within the 
top ',no.proteins, 'proteins is ',result_alpha)) 
result_alpha 
no_TP=votesum_TP(result_alpha,no.proteins,searchEngines) 
no_TP[length(no_TP)] 
 
 
##output with the data and protein information with the vote sum 
 
searchEng_p=matrix(rep(NA,protcount*no_engines),nrow=protcount,ncol=no_engines) 
vot_sum=rep(NA,protcount) 
 
for (i in 1:protcount){ 
 for(j in 1:no_engines){ 
 if(!is.na(searchEngines[i,j])&&searchEngines[i,j]<=result_alpha) 
  searchEng_p[i,j]=1 
 else 
  searchEng_p[i,j]=0 
} 
vot_sum[i]=sum(searchEng_p[i,]) 
} 
 
 
list=data.frame(data,vot_sum) 
sort.vot <- list[order(vot_sum,-searchEngines[,1],-searchEngines[,2],decreasing = 
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TRUE) , ] 
write.table(sort.vot,"output path",sep="\t",row.names =F) 
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APPENDIX D 
 
Supplementary Material 4 
Peptides Corresponding to Peptide Groups in ASW480 dataset Table S2 
 
Peptide 
Group 
1 2 3 4 5 6 
Peptide
s 
ELYEEELR EYQDLLN
VK 
KLLEGE
ESR 
LLEGE
ESR 
TNEKVELQE
LNDR 
DGQVINETSQHHDD
LE 
 NISEAEEWYK       VELQELNDR DNLAEDIMR 
 VYQVSRTSGGA
GGLGSLRASR 
        EEAENTLQSFR 
           EKLQEEMLQR 
           ELRRQVDQLTNDK 
           EMEENFAVEAANY
QDTIGR 
           EM1EENFAVEAANY
QDTIGR 
           ETNLDSLPLVDTH 
           ETNLDSLPLVDTHSK 
           FADLSEAANR 
           FANYIDK 
           FAVEAANYQDTIGR 
           GTNESLER 
           ILLAELEQLK 
           ISLPLPNFSSLNLR 
           KVESLQEEIAFLK 
           LGDLYEEEMR 
           LGDLYEEEM1R 
           LHEEEIQELQAQ 
           LHEEEIQELQAQIQE
QH 
           LLQDSVDFSLADAIN
TEFK 
           LQDEIQNMK 
           LQDEIQNM1K 
           LQDEIQNMKEEM 
           LQDEIQNMKEEM 
           LQDEIQNMKEEMA
R 
           LQDEIQNMKEEMA
R 
74 
 
           LQEEMLQR 
           MALDIEIATYR 
           NLQEAEEWYK 
           QDVDNASLAR 
           QESTEYR 
           QQYESVAAK 
           QVDQLTNDK 
           QVQSLTCEVDALK 
           SLTCEVDALK 
      SLYASSPGGVYATR 
      SVSSSSYR 
      SYVTTSTR 
      TCEVDALK 
      TYSLGSALRPSTSR 
      VESLQEEIAFLK 
      VEVERDNLAEDIMR 
      VQIDVDVSKPDLTA
ALR 
      SLYASSPGGVYATR 
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Supplementary Material 5 
Peptides Corresponding to Peptide Groups in HNSCC dataset Table S3 
 
Peptid
e 
Group 
1 2 3 4 5 
Peptid
es 
AEAELCAEAEETR EDQSILCTGESGAGK EEELQAALAR ALELDPN
LYR 
IFEYIDR/IFE
YLDR 
 ALEEEQEAR EDQSILCTGESGAGK
TENTK 
QLLQANPILEAF
GNAK 
    
 AQAELENVSGALNEA
ESK 
FDQLLAEEK      
 AQVTELEDELTAAED
AK 
KFDQLLAEEK       
 DLGEELEALR         
 DLQGRDEAGEER         
 EAEALTQR         
 EAQAALAEAQEDLES
ER 
        
 EEIFSQNR         
 ELQTAQAQLSEWR         
 ELSSTEAQLHDAQELL
QEETR 
        
 EQLEEEAAAR         
 EVGELQGR         
 EVVLQVEEER         
 FEEDLLLLEDQNSK         
 FEEDLLLLEDQNSKLS
K 
        
 GELEDTLDSTNAQQE
LR 
        
 GLEAEVLR         
 KFEEDLLLLEDQNSK         
 LAEFSSQAAEEEEK         
 LALEAEVSELR         
 LAQAEEQLEQETR         
 LAQLEEER         
 LELQLQEVQGR         
 LGEEDAGAR         
 LLGLGVTDFSR         
 LQEELAASDR         
 QDEVLQAR         
 QDEVLQAR         
 QDEVLQARAQELQK         
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 QEEEAGALEAGEEAR         
 QLEEAEEEASR         
 RQEEEAGALEAGEEA
R 
        
 RQLEEAEEEASR         
 TLEEETR         
 VAEQAANDLR         
 VAQLEEER         
 VGEEEECSR         
 
